Entry stagePre-seed, Seed, Series A, Series B
Check sizen/a
Leads roundsYes
FocusHealthtech, Life sciences, Deep tech
Latest fund$900M$900M — Foresite Capital Fund VI
Investing team13 peopleNo activity since Sep
Who you would pitch at Foresite Capital
13 people on the investing team, 2 of them partners who can make the call. Partners are listed first.
Hyung Chun, MDPartnerHe previously held academic roles at Yale School of Medicine and continues as adjunct faculty.
Shannon BergstedtPartnerFocus: life sciences and healthcare technology.
Collin Yang-WongPrincipalFocus: biotech investments.
Deepak Atri, MDPrincipalHe evaluates biotech and healthcare investments, with a background as a physician-scientist and clinical training.
Vishal Deshmukh, PhDPrincipalFocus: biotech investments.
Insiya EssaniSenior AssociateFocus: therapeutics investments.
Jorge Reis-Filho, MD, PhD, FRCPathVenture PartnerHe previously held leadership roles at AstraZeneca and Memorial Sloan Kettering Cancer Center.
Liang Chang, PhDVenture PartnerHe previously worked at Aditum Bio, Cure Ventures, 5AM Ventures, and Flagship Pioneering, and holds a PhD from Harvard.
Melia Granath PaneloAssociateFocus: biotech and therapeutics investments.
Mike Lai, MDVenture PartnerHe brings nearly 20 years of pharmaceutical industry experience, including roles at AstraZeneca and Sanofi.
Peter Wung, MD, MHSVenture PartnerHe has 15 years of pharmaceutical industry experience, including roles at Candid Therapeutics, Kyverna Therapeutics, AbbVie, and Sanofi.
Travis Young, PhDVenture PartnerHe previously spent 14 years at Scripps Research and Calibr-Skaggs, and holds a PhD from Scripps Research, with postdoctoral training at Harvard…
Uplaksh KumarVenture PartnerHe co-founded RoosterBio and has held leadership roles at several life sciences companies.
Work here and something is wrong? Ask for a correction.
Check size not reported yet.
Bars: how many firms in the atlas report each band. Highlighted: this firm.No recent activity since September 2026. Quiet does not mean closed.
Weekly count of activity updates. Activity is not a confirmed deal.Notable investments
April 4
In their words
Foresite Capital | Investing In Healthcare and Life SciencesWe are a multi-stage investment firm, investing in companies that leverage biology and big data to transform healthcare.www.foresitecapital.com
Send Mode VC your deck
Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckAlert me when Foresite Capital is active
One email when this firm shows new activity. Nothing else.
Firms like Foresite Capital
On these lists
Seed deep tech investors in California94Seed healthtech investors in California92Series A healthtech investors in California75Seed life sciences investors in California71Series A deep tech investors in California68Series A life sciences investors in California65Pre-seed deep tech investors in California52Pre-seed healthtech investors in California48
Questions
What stage does Foresite Capital invest in?
Foresite Capital reports entry at pre-seed, seed, series a, series b.
How much does Foresite Capital invest?
Foresite Capital has not reported a check size.
Does Foresite Capital lead rounds?
Yes. Foresite Capital says it can lead.
Who are the partners at Foresite Capital?
Hyung Chun, MD (Partner), Shannon Bergstedt (Partner).
Is Foresite Capital active right now?
No recent activity since September 2026.
Work at Foresite Capital? Claim or correct this profile.